Acurx Pharmaceuticals, Inc.
ACXP
$1.43
$0.00-0.07%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.14% | 22.48% | 27.92% | -2.59% | 30.58% |
| Total Receivables | 69.27% | 16.32% | 20.40% | 0.00% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.88% | 169.18% | -46.27% | 195.70% | -66.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 15.14% | 24.07% | 25.95% | -0.86% | 28.14% |
|
|
|||||
| Total Current Assets | 15.14% | 24.07% | 25.95% | -0.86% | 28.14% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 15.14% | 24.07% | 25.95% | -0.86% | 28.14% |
|
|
|||||
| Total Accounts Payable | 11.76% | -50.00% | 54.55% | 0.00% | 29.41% |
| Total Accrued Expenses | 12.11% | 4.53% | -2.02% | -4.77% | 3.87% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 12.11% | 4.37% | -1.92% | -4.76% | 3.91% |
|
|
|||||
| Total Current Liabilities | 12.11% | 4.37% | -1.92% | -4.76% | 3.91% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.11% | 4.37% | -1.92% | -4.76% | 3.91% |
|
|
|||||
| Common Stock & APIC | 4.04% | 4.25% | 4.15% | 2.74% | 4.88% |
| Retained Earnings | -2.93% | -2.23% | -2.14% | -2.78% | -3.23% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 16.24% | 33.11% | 44.86% | 1.98% | 54.29% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16.24% | 33.11% | 44.86% | 1.98% | 54.29% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 16.24% | 33.11% | 44.86% | 1.98% | 54.29% |
|
|
|||||